Ovarian Fallopian Tube Or Primary Peritoneal Carcinoma clinical trials

Explore recruiting ovarian fallopian tube or primary peritoneal carcinoma clinical trials.

Recruiting ovarian fallopian tube or primary peritoneal carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Ovarian Fallopian Tube Or Primary Peritoneal Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Randomized, Double-Blind Study of Pembrolizumab versus Placebo in Combination With Paclitaxel With or Without Bevacizumab for the Treatment of Platinum-resistant Recurrent Ovarian Cancer (KEYNOTE-B96 / ENGOT-ov65).

Finland, Germany, Italy, Denmark, France, Norway +4 more

Phase III and phase IV (Integrated) EU CTIS Study details

A phase 1 study to evaluate the dose, safety and tolerability of a radionuclide therapy (Radspherin®) in patients with platinum sensitive recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma with peritoneal carcinomatosis following complete surgical resection

Spain, Norway, Belgium

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Ovarian Fallopian Tube Or Primary Peritoneal Carcinoma trials by city

Ovarian Fallopian Tube Or Primary Peritoneal Carcinoma in Toronto Ovarian Fallopian Tube Or Primary Peritoneal Carcinoma in Vancouver Ovarian Fallopian Tube Or Primary Peritoneal Carcinoma in Montreal Ovarian Fallopian Tube Or Primary Peritoneal Carcinoma in Calgary Ovarian Fallopian Tube Or Primary Peritoneal Carcinoma in Edmonton Ovarian Fallopian Tube Or Primary Peritoneal Carcinoma in Ottawa Ovarian Fallopian Tube Or Primary Peritoneal Carcinoma in Winnipeg Ovarian Fallopian Tube Or Primary Peritoneal Carcinoma in Quebec City Ovarian Fallopian Tube Or Primary Peritoneal Carcinoma in Hamilton Ovarian Fallopian Tube Or Primary Peritoneal Carcinoma in Kitchener Ovarian Fallopian Tube Or Primary Peritoneal Carcinoma in London Ovarian Fallopian Tube Or Primary Peritoneal Carcinoma in Halifax Ovarian Fallopian Tube Or Primary Peritoneal Carcinoma in New York Ovarian Fallopian Tube Or Primary Peritoneal Carcinoma in Los Angeles Ovarian Fallopian Tube Or Primary Peritoneal Carcinoma in Chicago Ovarian Fallopian Tube Or Primary Peritoneal Carcinoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease